GlassScriptPhysician profile
Bennett Todd Baquet
NPI 1073563631
$29,950.02
in general payments reported to CMS, 2019-2025
56 companies · $1,426 in 2025
The $1,426 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,833 · 2020: $7,254 · 2021: $11K · 2022: $1,066 · 2023: $634 · 2024: $1,104 · 2025: $1,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,163.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $22,537.61 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $1,830.72 | 2019-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $674.05 | 2019-2025 | Tepezza, Tavneos, Prolia |
| Medtronic, INC. | $405.32 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Novo Nordisk INC | $338.68 | 2019-2025 | Ozempic |
| Lilly USA, LLC | $308.65 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $305.86 | 2019-2023 | |
| Horizon Therapeutics Plc | $240.92 | 2019-2023 | Tepezza |
| Abbott Laboratories | $239.21 | 2019-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $220.37 | 2019-2025 | |
| Radius Health, INC. | $219.95 | 2019-2025 | Tymlos |
| Merck Sharp & Dohme LLC | $201.83 | 2019-2023 | Steglatro, Steglujan |
| Corcept Therapeutics | $184.75 | 2019-2024 | Korlym |
| Aurinia Pharma U.S., INC. | $181.73 | 2021-2025 | Lupkynis |
| Ucb, INC. | $166.88 | 2019-2025 | Bimzelx |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $143.17 | 2019-2025 | Omnipod |
| Sequel Med Tech, LLC | $138.86 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $137.55 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.58 | 2019-2025 | Ofev, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $106.34 | 2019-2021 | |
| Beta Bionics, INC. | $99.08 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Amarin Pharma, INC. | $89.68 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $87.97 | 2021-2024 | Acthar |
| Alexion Pharmaceuticals, INC. | $71.83 | 2019-2024 | Strensiq |
| Ascendis Pharma Endocrinology INC | $66.30 | 2023-2025 | Yorvipath |
| Ani Pharmaceuticals, INC. | $61.52 | 2023-2025 | Purified Cortrophin Gel |
| Esperion Therapeutics, INC. | $55.15 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $44.77 | 2021-2024 | Isturisa, Signifor Lar |
| Abbvie INC. | $44.33 | 2021-2023 | Synthroid |
| Ibsa Pharma INC. | $41.68 | 2022-2024 | Flector, Licart, Tirosint |
| Chiesi USA, INC. | $39.34 | 2024-2025 | Mycapssa |
| Companion Medical, INC. | $35.74 | 2019-2020 | |
| Kyowa Kirin, INC. | $35.66 | 2024 | Crysvita |
| Clarus Therapeutics INC. | $35.54 | 2021 | |
| Shire North American Group INC | $32.02 | 2019 | |
| Acella Pharmaceuticals, LLC | $30.95 | 2022-2023 | NP Thyroid 60 |
| Roche Diabetes Care, INC. | $28.00 | 2019 | |
| Amneal Pharmaceuticals LLC | $25.59 | 2020-2024 | Unithroid |
| Janssen Pharmaceuticals, INC | $25.32 | 2020 | |
| Amryt Pharma Holdings LTD | $25.24 | 2023 | Mycapssa |
| Fresenius Kabi USA, LLC | $25.12 | 2023 | Idacio |
| Organon LLC | $24.71 | 2025 | Renflexis |
| Becton, Dickinson and Company | $22.88 | 2022 | |
| Janssen Biotech, INC. | $19.84 | 2023 | Tremfya |
| Madrigal Pharmaceuticals | $18.58 | 2025 | Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $17.89 | 2022 | |
| Neurocrine Biosciences, INC. | $17.69 | 2025 | |
| Zealand Pharma US, INC. | $16.90 | 2021 | |
| Cequr Corporation | $16.58 | 2025 | Cequr Simplicity |
| Ultragenyx Pharmaceutical INC. | $15.84 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $15.41 | 2025 | Imcivree |
| Sandoz INC. | $14.58 | 2025 | |
| Pfizer INC. | $14.37 | 2019 | |
| Medexus Pharma, INC. | $14.20 | 2019 | |
| Antares Pharma, INC. | $13.58 | 2021 | |
| Vivus LLC | $10.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bennett Baquet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.